A director at Lexicon Pharmaceuticals Inc bought 268,497 shares at 1.314USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Upwork Announces $300 Million Share Repurchase Program New authorization will contribute to $600 million in total share repurchase authorizations since November 2023 PALO ALTO, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that its board of directors approved a new $300 million share repurchase program. “2025 was a pivotal year for Upwork, as we returned to GSV growth and delivered record financial results,” said Hayden Brown, president and CEO, Upwork. “Our performance and strong balance sheet position us ...
Upwork to Present at The Citizens Technology Conference PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that President and CEO Hayden Brown and CFO Erica Gessert will participate in a fireside chat at The Citizens Technology Conference in San Francisco, CA on Monday, March 2, 2026 at 11:30 a.m. PT/2:30 p.m. ET. A live webcast of the fireside chat will be available in the Events and Presentations section of Upwork’s Investor Relations website at . A webcast archive will be available following the even...
Upwork Reports Fourth Quarter and Full Year 2025 Financial Results Record full-year 2025 revenue of $787.8 million Fourth-quarter revenue of $198.4 million and GAAP net income of $15.6 million Fourth-quarter adjusted EBITDA of $52.9 million or 27% adjusted EBITDA margin Full-year 2025 GAAP net income of $115.4 million and record adjusted EBITDA of $225.6 million or 29% adjusted EBITDA margin PALO ALTO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced its financial results for the fourth quarter and...
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001, and concurrent private placement of 22,400,000 shares of common stock and 367,145 shares of series b convertible preferred stock (the “Series B Convertible Preferred Stock”). The shares of common stock offered pursuant to the publi...
Upwork’s In-Demand Skills 2026: Demand for Top AI Skills More Than Doubles as AI Is Embedded Into Everyday Work Hiring data shows AI becoming part of everyday work, while demand for human expertise remains strong PALO ALTO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today released its annual , finding that as demand for top AI-enabled skills more than doubled year-over-year, hiring for human expertise remains strong across work categories. Now in its sixth year, the report finds that demand for the most in-demand skills...
A director at Sunrun Inc sold 50,000 shares at 18.595USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Sunrun Builds the Nation’s Largest Distributed Power Plant After Quintupling Customer Participation in 2025 Sunrun scales the nation’s largest distributed power plant with 400% growth, 17 programs, major partnerships, and record grid dispatches as AI-driven electricity demand surges SAN FRANCISCO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- With rising electricity costs, growing risk of power outages, and a widening gap between power supply and demand, Sunrun (Nasdaq: RUN), America’s largest provider of home battery storage, solar, and home-to-grid power plants, rapidly delivered new, dispatchabl...
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001. The shares of common stock being offered pursuant to the public offering are being offered at a public offering price of $1.30 per share. All of the shares are being offered by Lexicon. The gross proceeds from the public offering a...
Lexicon Announces Proposed Public Offering of Common Stock THE WOODLANDS, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced that it has commenced an underwritten public offering to offer and sell, subject to market and other conditions, shares of its common stock, par value $0.001. In addition, Lexicon intends to grant the underwriters a 30-day option to purchase additional shares of common stock. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the p...
Sunrun Announces Date for Fourth Quarter and Full-year 2025 Earnings Report Earnings Release and Conference Call Scheduled for February 26, 2026 SAN FRANCISCO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) today announced that it will issue its fourth quarter and full-year 2025 earnings report after the market closes on Thursday, February 26, 2026. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at or over the phone by dialing (877) 407-5989 (to...
Frequency Electronics Inc. Announces a contract award valued at approximately $6.0 million MITCHEL FIELD, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the follow-on award of several contracts from a major aerospace company for precision “g” (acceleration) compensated Oven-controlled Quartz Oscillators (OCXO) for ultimate application in US Government software-defined radio systems. These precision...
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, 2026. The event will commemorate Lexicon’s 30th anniversary as a biopharmaceutical company building a differentiated pipeline of oral small-molecule therapies for people living with serious cardiometabolic diseases and chronic neuropathic pain. “In its early days, Lexicon was focused on pioneering a deeper understa...
Lexicon Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA For Pilavapadin in the Treatment of Diabetic Peripheral Neuropathic Pain – No objections raised by FDA to advancement of pilavapadin into Phase 3 development utilizing two-arm registrational studies of 10 mg daily dose compared to placebo – THE WOODLANDS, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced the successful completion of the End-of-Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) for pilavapadin in diabetic peripheral neuropathic pain (DPNP). During the ...
Upwork to Report Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026 PALO ALTO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that it will report its financial results for the fourth quarter and full year of 2025 on Monday, February 9, 2026 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the call will be available on the Upwork Investor Relations website at . An a...
FEI-Zyfer Announces Contract Awards for Approximately $6.0 Million Garden Grove, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- FEI-Zyfer, Inc., a wholly-owned subsidiary of Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, is pleased to announce the receipt of contracts totaling approximately $6.0 million in two of our core business areas for Assured-PNT (Position Navigation and Timing) – for secure communications systems and for time, frequency, and synchronization distribution systems in support of airb...
Lexicon Pharmaceuticals Provides a Business and Pipeline Update at the 44th Annual J.P. Morgan Healthcare Conference SONATA-HCM on track for enrollment completion in 2026 and topline data in 2027 $10 million milestone payment triggered from licensing agreement with Novo Nordisk for LX9851 Zynquista on track for NDA resubmission and potential approval in 2026 Company presentation January 15 at 12:00 p.m. PT (3:00 p.m. ET) THE WOODLANDS, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a business and pipeline update at...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.